Arthritis drug shortage looms

TGA working with wholesalers to restrict available Actemra stock to community pharmacies and hospitals as stocks dwindle Australia faces a shortage of arthritis drug Actemra (tocilizumab) following recommendation by the World Health Organisation as treatment for patients seriously ill COVID-19. Shortages of some iterations of the interleukin-6 (IL6) receptor blocker class drug may, in some